X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (248) 248
Publication (12) 12
Book Review (5) 5
Book Chapter (2) 2
Newspaper Article (2) 2
Patent (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (121) 121
oncology (91) 91
melanoma (74) 74
female (66) 66
male (64) 64
melanoma - drug therapy (62) 62
middle aged (61) 61
index medicus (59) 59
aged (57) 57
adult (51) 51
immunotherapy (42) 42
cancer (40) 40
melanoma - pathology (40) 40
skin neoplasms - pathology (35) 35
chemotherapy (33) 33
skin neoplasms - drug therapy (33) 33
treatment outcome (33) 33
metastasis (30) 30
care and treatment (29) 29
metastatic melanoma (29) 29
malignant-melanoma (28) 28
neoplasm staging (27) 27
aged, 80 and over (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
antineoplastic agents - therapeutic use (24) 24
melanoma - mortality (24) 24
melanoma - secondary (24) 24
melanoma - therapy (21) 21
disease-free survival (20) 20
survival rate (20) 20
antineoplastic combined chemotherapy protocols - adverse effects (19) 19
antineoplastic agents - administration & dosage (18) 18
adjuvant therapy (17) 17
clinical trials (17) 17
ipilimumab (17) 17
prognosis (17) 17
chemotherapy, adjuvant (16) 16
research (16) 16
survival (16) 16
therapy (16) 16
dacarbazine (15) 15
interleukin-2 (15) 15
medicine, research & experimental (15) 15
skin neoplasms - mortality (15) 15
clinical trials as topic (14) 14
drug therapy (13) 13
recombinant proteins (13) 13
trial (13) 13
dacarbazine - administration & dosage (12) 12
drug administration schedule (12) 12
medicine & public health (12) 12
melanoma - immunology (12) 12
melanoma - surgery (12) 12
neoplasm metastasis (12) 12
neoplasms - drug therapy (12) 12
survival analysis (12) 12
combined modality therapy (11) 11
cutaneous melanoma (11) 11
disease progression (11) 11
interleukin-2 - therapeutic use (11) 11
patient outcomes (11) 11
radiotherapy (11) 11
skin neoplasms - therapy (11) 11
time factors (11) 11
antineoplastic agents - adverse effects (10) 10
hematology, oncology and palliative medicine (10) 10
interferon-alpha - administration & dosage (10) 10
interferon-alpha - therapeutic use (10) 10
interleukin-2 - administration & dosage (10) 10
surgery (10) 10
antibodies, monoclonal - therapeutic use (9) 9
biomarkers (9) 9
cooperative-oncology-group (9) 9
dacarbazine - analogs & derivatives (9) 9
dermatology (9) 9
health aspects (9) 9
immunology (9) 9
kaplan-meier estimate (9) 9
patients (9) 9
risk factors (9) 9
temozolomide (9) 9
tumors (9) 9
analysis (8) 8
animals (8) 8
brain neoplasms - secondary (8) 8
cisplatin (8) 8
dacarbazine - therapeutic use (8) 8
dosage and administration (8) 8
immunotherapy - methods (8) 8
interferon (8) 8
medicine (8) 8
melanoma - genetics (8) 8
nivolumab (8) 8
pharmacology & pharmacy (8) 8
randomized trial (8) 8
skin neoplasms - surgery (8) 8
studies (8) 8
abridged index medicus (7) 7
interferon-alpha - adverse effects (7) 7
meeting report (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 908 - 918
Journal Article
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 05/2009, Volume 9, Issue 5, pp. 587 - 595
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 21, pp. 2006 - 2017
Journal Article
Melanoma Management, ISSN 2045-0885, 06/2016, Volume 3, Issue 2, pp. 113 - 123
Advances in treatment of melanoma with systemic immunotherapies continue, with promising findings for anti-PD-1 agents combined with ipilimumab. Still, an... 
nivolumab | locoregional disease control | in-transit metastases | PV-10 | hypophysitis | bystander lesion | T-VEC | pembrolizumab | cocksackie A21 virus | talimogene laherparepvec | ipilimumab | plasmid IL-12 electroporation | systemic immunotherapy
Journal Article
Seminars in Oncology, ISSN 0093-7754, 12/2015, Volume 42, Issue 6, pp. S20 - S27
Journal Article
Seminars in Oncology, ISSN 0093-7754, 12/2015, Volume 42, Issue 6, pp. S1 - S2
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2007, Volume 357, Issue 17, pp. 1705 - 1715
Journal Article
Melanoma Management, ISSN 2045-0885, 05/2015, Volume 2, Issue 2, pp. 101 - 103
Journal Article